Subsequent complementary work from several other laboratories has demonstrated that deregulation of the SK1/S1P pathway plays a role in carcinogenesis and promoting cancer cell viability as well as chemotherapeutic resistance 5, 6, 7, 8, 9. This evidence concerns the gene SPHK1 and cancer.